Gassert Chad 4

What Happened Chad Gassert, Senior Vice President — Corporate Development & Strategy at ANI Pharmaceuticals (ANIP), had a total of 3,325 shares withheld to satisfy tax liabilities related to the vesting of restricted stock. The filing shows 1,608 shares withheld on 2026-02-12 at $76.70 (value $123,334) and 1,717 shares withheld on 2026-02-14 at $77.36 (value $132,827), for a combined value of approximately $256,161. These transactions are tax-withholding dispositions (Form 4 code F), not open-market sales.

Key Details

• Transaction dates and amounts:
  • 2026-02-12: 1,608 shares withheld at $76.70 = $123,334
  • 2026-02-14: 1,717 shares withheld at $77.36 = $132,827
  • Total withheld: 3,325 shares; total value ≈ $256,161
• Purpose: Shares were withheld to cover tax obligations upon vesting of restricted stock (code F — payment of exercise price or tax liability).
• Footnotes:
  • F1: Withholding relates to vesting of 3,590 restricted shares (grant previously reported 2025-02-18).
  • F2: Withholding relates to vesting of 3,355 restricted shares (grant previously reported 2024-02-16).
  • F3: Reporting person (Gassert) holds voting and dispositive power over shares held by Chali Properties LLC.
• Shares owned after the transactions: not specified in the provided filing details.
• Filing date: Form was filed 2026-02-17 for transactions on 2026-02-12 and 2026-02-14. Form 4s are typically due within two business days of the transaction; the Feb 12 withholding appears to have been reported after that usual window.

Context Tax-withholding on vested restricted stock is a routine administrative event (sometimes called a cashless withholding) where the company retains shares to satisfy tax obligations. These dispositions generally do not reflect an insider actively selling shares on the open market and are typically less informative about the insider’s view of the company than outright purchases.